The US Food and Drug Administration (FDA) is still working on a plan to standardise a baseline level of regulation for CBD in dietary supplements, food and drinks – but many in the industry and at state level are weary of waiting
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields